Antioxidants preserve vision in retina disease

Article

Consumption of antioxidants may enable retinal degeneration patients to preserve vision even while vascular abnormalities continue to exist, concluded a study published online ahead of print by the Journal of Clinical Investigation.

Consumption of antioxidants may enable retinal degeneration patients to preserve vision even while vascular abnormalities continue to exist, concluded a study published online ahead of print by the Journal of Clinical Investigation.

Professor Martin Friedlander, MD, PhD of Scripps Research Institute, US and colleagues examined mice with dysfunctional VLDL receptors, which imitate abnormal retinal neovascularisation associated with death of the photoreceptor cells in humans. Such symptoms are associated with conditions such as retinal angiomatous proliferation (RAP) and macular telangiectasia (MacTel).

The team found that abnormalities of the intraretinal vasculature and associated neuronal cell death were correlated with increased oxidative stress markers; there oxidative stress markers were mediated either by nutritional antioxidant supplements or by targeted topical antioxidant delivery, although the presence of antioxidants had no impact on the existing vascular abnormalities.

Therefore the researchers concluded that, by reducing oxidative stress, photoreceptor cells could be preserved and functional vision maintained by RAP and MacTel patients even while retinal vasculature is not improved.

Recent Videos
David Yorston, FRCS, FRCOphth, discusses his EURETINA keynote lecture
Hoda Shamsnajafabadi, MSc, PhD, presents at the 2024 EURETINA meeting
Timothy L Jackson PhD, MB ChB, FRCOphth, speaks about a combination therapy for VEGF-A/C/D inhibition with sozinibercept and ranibizumab
Carl Awh, MD, FASRS, speaks about the American Society of Retina Specialists (ASRS) at EURETINA
Stefano Mercuri, MD, first author of the winning eposter “Genotype-phenotype correlations in a cohort of genetically determined Retinitis Pigmentosa (RP) Italian patients with Rho gene mutations”
Bahram Bodaghi, MD, PHD, FEBO at the 2024 EURETINA meeting
Enrico Borrelli, MD, FEBO, speaks at EURETINA
Aleksandra Rachitskaya, MD, FASRS, speaks about the Vit-Buckle Society at the 2024 EURETINA Congress.
© 2024 MJH Life Sciences

All rights reserved.